DDIT3 and hepatocellular carcinoma: Additionally, treatment with PD98058 (20 μM), an inhibitor of ERK1/2, significantly reversed the increase in ATF4 or CHOP mRNA expression in 5-FU resistant HCC cells (Figs. 2D and 2E).